Gip

Gip has been studied in 4 papers since 2023: 1 observational study in people, 1 in animals, 1 review; 1 in the past year. The newest paper, Oct 26, 2026: “Triple GLP-1R/GIP-R/GCGR activation synergistically suppresses macrophage-driven oxidative stress and activation in human epicardial adipose tissue from patients with a history of atrial fibrillation”.

4 papers study itUpdated Oct 26, 2026

1 new paper in 30 daysSee all 4

Humans1
Animals1

Latest

1 paper in 12 months

ESC Congress 2026 AbstractOct 26

Triple GLP-1R/GIP-R/GCGR activation synergistically suppresses macrophage-driven oxidative stress and activation in human epicardial adipose tissue from patients with a history of atrial fibrillation

Study of 20 peopleAtrial fibrillation

Journal of Cachexia, Sarcopenia and MuscleOct 28

Gastric inhibitory polypeptide receptor antagonism suppresses intramuscular adipose tissue accumulation and ameliorates sarcopenia

Experiments in miceMuscle

Clinical MedicineJul 1

Future therapies for obesity

BMJ OpenFeb 27

Separate and combined effects of long-term GIP and GLP-1 receptor activation in patients with type 2 diabetes: a structured summary of a study protocol for a double-blind, randomised, placebo-controlled clinical trial

Study protocolType 2 diabetes